319 Anxiety and depression symptoms in caregivers of children and adolescents with cystic fibrosis in Spain  by Cebrián, M. et al.
S130 15. Nursing/Psychosocial issues Posters
317 Depression, anxiety and quality of life in adolescents with cystic
ﬁbrosis
K. Harning1, A. Bergsten Brucefors1, L. Hjelte1. 1Karolinska University Hospital,
Stockholm, Sweden
Objectives: It has been shown that a chronic disease involves a signiﬁcant risk for
developing depression and anxiety symptoms. The impact of anxiety and depression
on quality of life is well known in adults but not among adolescents. The aim of
the study is to estimate the prevalence of depression and anxiety in adolescents
with CF and to describe their health-related quality of life.
Methods: 26 patients, age 12 to 17 were recruited. Mean age 15. Participants
completed the Hospital Anxiety and Depression Scale (HADS) including 14 items
on a Likkert scale (cut off mild = 7, severe = 10) and the Cystic Fibrosis Quality
of Life Questionnaire (CFQ-R) (8 sub-domains in proportions of 100%).
Results: HADS shows a depression mean of 2 (range 0−15) and an anxiety mean
of 4 (range 0−11). The CFQ-R sub-domains means: physical 88% (range 42–100),
emotional state 79% (range 46–100), social 78% (range 44–100), body image 82%
(range 44–100), eating 86% (range 22–100), treatment burden 63% (range 0−89),
respiratory 76% (range 50–100), digestion 74% (range 33–100).
Conclusions: Anxiety and depressive symptoms are not very common among CF
adolescents at Stockholm CF-center but there are some patients that suffer from both
depression and anxiety. The symptoms of anxiety appears to occur to a greater extent
than depression. Among the domains of CF quality of life the treatment burden was
the most troubling. A routine screening for symptoms of anxiety, depression and
health-related quality of life is important in the prevention of mental illness. Those
identiﬁed with elevated clinical symptoms need appropriate treatment.
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Individuals with chronic conditions, such as cystic ﬁbrosis (CF), are at increased
risk for symptoms of anxiety and depression. These symptoms have been linked
to worse adherence and worse health outcomes. However, little is known about the
prevalence and impact of these symptoms on patients with CF in Spain. The aim
of this study was to measure the prevalence of these symptoms at several centers
in Spain.
Methods: A representative sample of Spanish patients with CF (N= 439; 51.94%
men; age range: 12−80 years) completed the Hospital Anxiety and Depression
Scale (HADS) and the Center for Epidemiologic Studies Depression Scale (CES-D).
Clinical and demographic data were collected from their charts.
Results: A high percentage of patients scored over the clinical cut-off on both scales
(CES-D: 28.92%; HADS depression 10.93%; HADS anxiety: 27.56%). Women had
higher anxiety scores and younger patients reported fewer symptoms of anxiety and
depression than older patients. Recent episodes of hemoptysis or pneumothorax,
IV treatment, or listing for lung transplantation predicted higher depression scores.
Patients with less education, pancreatic sufﬁciency and better adherence reported
more symptoms of anxiety.
Conclusions: Signiﬁcant elevations in depression and anxiety were found in patients
with CF in Spain and were associated with clinical outcomes. Although quite
common, only 24.4% of patients with these elevations were receiving psychological
or pharmacological treatment. Annual screening of symptoms of anxiety and
depression should be performed, with appropriate referrals for those at risk.
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Caregivers of children and adolescents with chronic illnesses are at higher risk for
symptoms of depression and anxiety. Our aim was to evaluate the prevalence of
these symptoms in parent caregivers of children and adolescents with cystic ﬁbrosis
(CF) in Spain.
Methods: 276 parents of 250 children with CF ages 0−17 completed the Hospital
Anxiety Depression Scale (HADS) and the Center for Epidemiologic Studies
Depression Scale (CES-D). Clinical and demographic data were collected from
patients’ clinical charts.
Results: High rates of depression and anxiety were reported by caregivers: CES-D:
53.98%; HADS Depression: 32.60%; HADS Anxiety: 61.59%. Caregivers of
children younger vs. older than 12 reported more symptoms of depression and
anxiety and mothers reported more symptoms than fathers. Symptoms of both
depression and anxiety were more elevated in caregivers whose children recently
received intravenous antibiotics or were listed for transplantation. Higher symptom
scores were also associated with an increased number of hospitalizations and
pulmonary exacerbations in the last year. Depressive symptoms were related to
enteral feeding and patient’s receipt of psychotherapy. Symptoms of anxiety were
signiﬁcantly associated with a recent diagnosis of CF-related diabetes.
Conclusions: Despite the large percentages of caregivers endorsing these psycho-
logical symptoms, only 18% received treatment. To prevent elevations in depression
and anxiety and their consequences for patients’ disease management and health
outcomes, annual screening should be performed, with appropriate referrals for
parents with elevated risk factors or symptoms.
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Objectives: Anxiety (A) and depression (D) are the most common neuropsychiatric
features in patients with CF. The purpose of this study is to characterize the psycho-
logical status of patients with CF, and to investigate the relationship between these
psychological characteristics with clinical factors.
Methods: Participants included 409 patients with CF (aged 12−69) who completed
structured questionnaires assessing respondent characteristics [socioeconomic sta-
tus (SES), age] and well-being (HADS; CES-D). Variables with clinical data (patients
with a Port-A-Cath, intravenous antibiotic treatment and severe lung function) were
analyzed with multiple regression.
Table: Multiple regression analysis predicting D & A
B(D) SE B(D) b (D) B(A) SE B(A) b (A)
Step 1 constant 4.25 1.30 4.37 0.47
age 0.27 0.05 0.28*** 0.08 0.02 0.22***
Step 2 constant 1.10 1.43 3.89 0.52
age 0.26 0.05 0.26*** 0.08 0.02 0.21***
SES 0.80 1.17 0.22*** 0.13 0.06 0.10*
Step 3 constant 0.72 1.45 3.79 0.54
age 0.25 0.05 0.25*** 0.07 0.02 0.20***
SES 0.75 0.17 0.21*** 0.13 0.06 0.10*
PAC/IV-antibiotics 1.46/1.69 1.43/1.02 0.05/0.06 0.13/0.36 0.55/0.39 0.01/0.05
Note R2 = 0.08 for Step 1 (D); DR2 = 0.05 for Step 2 (ps< 0.001); DR2 = 0.01 for Step 3; R2 = 0.05
for Step 1 (A); DR2 = 0.01 for Step 2 (ps< 0.05); DR2 = 0.003 for Step 3; *p< 0.05; ***p< 0.001.
Conclusion: The results showed that 15.3% of all patients were depressed and 33.3%
of all patients were anxious as measured on the HADS, regardless of the cutoff criteria.
This study presents evidence that anxiety and depression are independently associated
with age and SES but neither anxiety nor depression were associated with clinical
predictors.
